Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

While the cost of medication isn’t included in the monthly plan cost, tirzepatide is available for about $130 per month with insurance, making it the most affordable option for individuals with ...

Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded ...

The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...

Its generic version is tirzepatide, but it is only available as Mounjaro. It can help boost insulin production when necessary, reduce sugar production in the liver, and slow down digestion.

Both Ozempic and Mounjaro are approved by the FDA to treat Type 2 diabetes, but some doctors prescribe the medication ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Novo Nordisk seeks to put a stop to semaglutide compounding, whereas the FDA agrees to allow compounding of tirzepatide, for ...